hims retatrutide FDA Blocks & Hers $49 Compounded Wegovy Pill: What to Know Retatrutide, an experimental weight-loss drug,

Earlier this week, the company Hims, arguably the best-known source of compounded GLP-1s, announced that it would stop marketing these drugs as part of a truce formed with Novo Nordisk

Eli Lilly now has the primary efficacy dataset required for an NDA filing, which remains expected before the end of 2026 pending TRIUMPH-2 data

For the rest of this article, Ill refer to these medications as AOMs for accuracy sake

Readers are encouraged to check ClinicalTrials.gov and Eli Lilly's official communications for the most current trial status, as this information may change

So when a large new study hints at a link between GLP-1 receptor agonists and a rare but serious eye condition, it makes sense that people are nervous

GLP 1 hormones play a natural role in appetite regulation, blood sugar control, insulin sensitivity, and satiety